Cargando…
Deciphering the Iron Side of Stroke: Neurodegeneration at the Crossroads Between Iron Dyshomeostasis, Excitotoxicity, and Ferroptosis
In general, iron represents a double-edged sword in metabolism in most tissues, especially in the brain. Although the high metabolic demands of brain cells require iron as a redox-active metal for ATP-producing enzymes, the brain is highly vulnerable to the devastating consequences of excessive iron...
Autores principales: | DeGregorio-Rocasolano, Núria, Martí-Sistac, Octavi, Gasull, Teresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389709/ https://www.ncbi.nlm.nih.gov/pubmed/30837827 http://dx.doi.org/10.3389/fnins.2019.00085 |
Ejemplares similares
-
Targeting Pro-Oxidant Iron with Exogenously Administered Apotransferrin Provides Benefits Associated with Changes in Crucial Cellular Iron Gate Protein TfR in a Model of Intracerebral Hemorrhagic Stroke in Mice
por: García-Serran, Alexia, et al.
Publicado: (2023) -
Relevance of Porcine Stroke Models to Bridge the Gap from Pre-Clinical Findings to Clinical Implementation
por: Melià-Sorolla, Marc, et al.
Publicado: (2020) -
Iron-loaded transferrin (Tf) is detrimental whereas iron-free Tf confers protection against brain ischemia by modifying blood Tf saturation and subsequent neuronal damage
por: DeGregorio-Rocasolano, Nuria, et al.
Publicado: (2017) -
Comparative Proteomics Unveils LRRFIP1 as a New Player in the DAPK1 Interactome of Neurons Exposed to Oxygen and Glucose Deprivation
por: DeGregorio-Rocasolano, Núria, et al.
Publicado: (2020) -
Targeting Pro-Oxidant Iron with Deferoxamine as a Treatment for Ischemic Stroke: Safety and Optimal Dose Selection in a Randomized Clinical Trial
por: Millán, Mònica, et al.
Publicado: (2021)